You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Starting dose

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Advanced or Metastatic Solid Tumor, Liver Failure Trial in United States (Sacituzumab Govitecan-hziy)

Recruiting
  • Advanced or Metastatic Solid Tumor
  • Liver Failure
  • Sacituzumab Govitecan-hziy
  • Long Beach, California
  • +5 more
Jan 6, 2023

Infertility Trial in Alicante (REKOVELLE (Follitropin Delta), GONAL-F (Follitropin Alfa))

Recruiting
  • Infertility
  • REKOVELLE (Follitropin Delta)
  • GONAL-F (Follitropin Alfa)
  • Alicante, Spain
    Ferring investigational site
Jul 21, 2022

Infertility Trial in Changsha (300IU rFSH Gonal-F® starting dose during controlled ovarian stimulation, 150IU rFSH Gonal-F®

Recruiting
  • Infertility
  • 300IU rFSH Gonal-F® starting dose during controlled ovarian stimulation
  • 150IU rFSH Gonal-F® starting dose during controlled ovarian stimulation
  • Changsha, Hunan, China
    Reproductive & Genetic Hospital of CITIC-XIANGYA
Jan 10, 2022

Idiopathic Pulmonary Fibrosis Trial (CHF10067 starting dose, CHF10067 intermediate dose, CHF10067 high dose)

Not yet recruiting
  • Idiopathic Pulmonary Fibrosis
  • CHF10067 starting dose
  • +3 more
  • (no location specified)
Aug 22, 2022

Agitation, Delirium Trial in Nashville (BXCL501, Placebo film)

Withdrawn
  • Agitation
  • Delirium
  • Nashville, Tennessee
    BioXcel Clinical Research Site
Apr 1, 2022

Acute Myeloid Leukemia, T Cell Acute Lymphoblastic Leukemia, T Cell Lymphoblastic Lymphoma Trial in Milwaukee (XmAb18968 - Dose

Recruiting
  • Acute Myeloid Leukemia
  • +2 more
  • XmAb18968 - Dose level -1
  • +4 more
  • Milwaukee, Wisconsin
    Froedtert Hospital & the Medical College of Wisconsin
Feb 15, 2022

Hepatocellular Carcinoma (HCC), Second Line Treatment Trial in Germany (Cabozantinib Oral Tablet)

Recruiting
  • Hepatocellular Carcinoma (HCC)
  • Second Line Treatment
  • Cabozantinib Oral Tablet
  • Bad Saarow, Germany
  • +9 more
Mar 29, 2022

Anemia, Renal Insufficiency, Chronic Trial in Worldwide (Mircera)

Completed
Has Results
  • Anemia
  • Renal Insufficiency, Chronic
  • Birmingham, Alabama
  • +21 more
Mar 3, 2022

Thyroid Cancer Trial in Worldwide (Lenvatinib, Lenvatinib matching )

Completed
Has Results
  • Thyroid Cancer
  • La Jolla, California
  • +100 more
Oct 28, 2021

Coronary Artery Disease Trial in Germany (Vericiguat (BAY1021189), Placebo, Isosorbide mononitrate (ISMN))

Completed
  • Coronary Artery Disease
  • Vericiguat (BAY1021189)
  • +2 more
  • Bad Krozingen, Baden-Württemberg, Germany
  • +5 more
Dec 9, 2021

Tay-Sachs Disease, Sandhoff Disease Trial in Boston, Worcester (AXO-AAV-GM2 Starting Dose, AXO-AAV-GM2 Low Dose, AXO-AAV-GM2

Recruiting
  • Tay-Sachs Disease
  • Sandhoff Disease
  • AXO-AAV-GM2 Starting Dose
  • +3 more
  • Boston, Massachusetts
  • +1 more
Jan 26, 2021

Multiple Myeloma Trial in New York (busulfan, melphalan and fludarabine)

Completed
Has Results
  • Multiple Myeloma
  • busulfan, melphalan and fludarabine
  • New York, New York
    Memorial Sloan Kettering Cancer Center
Nov 4, 2021

Dyslipidemias Trial in Belgium (Atorvastatin)

Completed
  • Dyslipidemias
  • Antwerpen, Belgium
  • +14 more
Feb 17, 2021

Infections, Rotavirus Trial in Worldwide (PCV-free liquid formulation of GSK's oral live attenuated HRV vaccine, Lyophilized

Completed
Has Results
  • Infections, Rotavirus
  • PCV-free liquid formulation of GSK's oral live attenuated HRV vaccine
  • Lyophilized formulation of GSK's oral live attenuated HRV vaccine
  • Birmingham, Alabama
  • +36 more
Feb 25, 2022

Heart Transplantation Trial in Germany, Basel (Everolimus)

Completed
  • Heart Transplantation
  • Germany, Germany
  • +1 more
Feb 8, 2020

Blasts Under 15 Percent of Bone Marrow Nucleated Cells, Blasts Under 15 Percent of Peripheral Blood White Cells, Blasts Under 30

Terminated
Has Results
  • Blasts Under 15 Percent of Bone Marrow Nucleated Cells
  • +4 more
  • Houston, Texas
    M D Anderson Cancer Center
Apr 22, 2020

Renal Cell Carcinoma, Ovarian Carcinoma, Thyroid Carcinoma Trial in Groningen (Olaparib, Lenvatinib, Sunitinib)

Not yet recruiting
  • Renal Cell Carcinoma
  • +4 more
  • Groningen, Netherlands
    University Medical Center Groningen
Jul 13, 2023

Type 2 Diabetes, T2D Trial in Worldwide (LY3209590, Insulin Glargine)

Recruiting
  • Type 2 Diabetes
  • T2D
  • Birmingham, Alabama
  • +71 more
Jan 26, 2023

Specialized Technology Education for Pumps & Pens in Underserved

Completed
  • Type1diabetes
  • Education: Session 1 - Basics of type 1 management
  • +5 more
  • Los Angeles, California
    University of Southern California Eastside Center for Diabetes
Sep 9, 2020

Breast Cancer Trial in Dallas (Radiomics on MRI)

Recruiting
  • Breast Cancer
  • Radiomics on MRI
  • Dallas, Texas
    University of Texas Southwestern Medical Center - Dallas
Nov 28, 2022

Sickle Cell Disease Trial in Durham (AB1)

Not yet recruiting
  • Sickle Cell Disease
  • Durham, North Carolina
    Duke University Medical Center
Jul 21, 2022

Solid Tumor, Non-Hodgkin's Lymphoma Trial in China, Taiwan (ATG-019, ATG-019 + Niacin ER)

Recruiting
  • Solid Tumor, Non-Hodgkin's Lymphoma
  • Nanjing, Jiangsu, China
  • +7 more
Aug 11, 2022

Opioid Use Disorder Trial (Fentanyl, Methadone, Slow-release oral morphine)

Not yet recruiting
  • Opioid Use Disorder
  • (no location specified)
Jun 7, 2023

Healthy Nutrition Trial in Skjetten (Jarlsberg cheese)

Completed
  • Healthy Nutrition
  • Jarlsberg cheese
  • Skjetten, Viken, Norway
    Meddoc
Jul 1, 2022

Healthy Aging Trial (Jarlsberg cheese)

Not yet recruiting
  • Healthy Aging
  • Jarlsberg cheese
  • (no location specified)
Jun 27, 2022